Tangji Gastric Bypass Stent Study for Obesity

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

May 3, 2022

Study Completion Date

October 7, 2022

Conditions
Obesity
Interventions
DEVICE

Gastric Bypass Stent System

Subjects will be treated with the Gastric Bypass Stent System implanted under gastroscopy. Following a 3-month treatment period, the device is removed, and subjects are followed for 6 months.

BEHAVIORAL

Dietary Intervention

The patients in the trial group or in the control group,have 9-month dietary intervention in the syudy period.

Trial Locations (7)

100000

Beijing Friendship Hospital,Capital Medical University, Beijing

100038

Beijing Shijitan Hospital, Capital Medical University, Beijing

210000

Nanjing Drum Tower hospital, Nanjing

300000

Tianjin Medical University General Hospital, Tianjin

Unknown

The First Hospital of China Medical University, Shenyang

The Affiliated Hospital of lnner Mongolia Medical University, Hohhot

Tangdu Hospital,Fouth Military Medical University, Xi’an

All Listed Sponsors
lead

Hangzhou Tangji Medical Technology Co., Ltd.

OTHER

NCT05938231 - Tangji Gastric Bypass Stent Study for Obesity | Biotech Hunter | Biotech Hunter